Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Dividends Paid - Common of -$78000.0 in Q4 2024, down 113.64% quarter-over-quarter from $572000.0 in Q2 2024.
Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024) Analysis & Trends
Maravai Lifesciences Holdings' Dividends Paid - Common history runs 5 years deep, the most recent figure standing at -$78000.0 for Q4 2024.
- In Q4 2024, Dividends Paid - Common changed N/A year-over-year to -$78000.0; the TTM figure through Sep 2025 stood at $494000.0 (down 13.64% YoY), while the FY2024 annual figure was $494000.0, down 94.86% from the prior year.
- Dividends Paid - Common was -$78000.0 for Q4 2024 at Maravai Lifesciences Holdings, down from $572000.0 in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $110.0 million in Q4 2021 to a low of -$78000.0 in Q4 2024.
- Historically, Dividends Paid - Common has averaged $31.6 million across 5 years, with a median of $30.9 million in 2022.
- The sharpest annual moves came in 2021 and 2023: Dividends Paid - Common jumped 40961.48% in 2021, then sank 96.94% in 2023.
- A 5-year view of Dividends Paid - Common shows it stood at $96.7 million in 2020, then climbed by 13.71% to $110.0 million in 2021, then sank by 71.89% to $30.9 million in 2022, then tumbled by 95.78% to $1.3 million in 2023, then tumbled by 105.98% to -$78000.0 in 2024.
- The last three Dividends Paid - Common figures came in at -$78000.0 (Q4 2024), $572000.0 (Q2 2024), and $1.3 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -78,000.00 |
| Dec 31, 2024 | -78,000.00 |
| Jun 30, 2024 | 572,000.00 |
| Jun 30, 2024 | 572,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 8.30 Mn |
| Mar 31, 2023 | 8.30 Mn |
| Dec 31, 2022 | 30.92 Mn |
| Dec 31, 2022 | 30.92 Mn |
| Sep 30, 2022 | 36.81 Mn |
| Sep 30, 2022 | 36.81 Mn |
| Jun 30, 2022 | 42.59 Mn |
| Jun 30, 2022 | 42.59 Mn |
| Mar 31, 2022 | 39.89 Mn |
| Mar 31, 2022 | 39.89 Mn |
| Dec 31, 2021 | 110.00 Mn |
| Dec 31, 2021 | 110.00 Mn |
| Sep 30, 2021 | 50.10 Mn |
| Sep 30, 2021 | 50.10 Mn |